Upstream Bio, Inc. UPB Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$156.76M-98.0% | -$143.44M-128% | -$122.23M-129% | -$104.47M-158% | -$79.18M-179% | ||
| $194K+63.0% | $188K+111% | $180K+233% | $148K— | $119K— | ||
| $12.34M+54.4% | $10.33M+72.1% | $9.91M+114% | $9.18M— | $8M— | ||
| -$139.96M-69.1% | -$133.28M-125% | -$122.26M-120% | -$113.98M— | -$82.78M— | ||
| —— | —— | —— | —— | —— | ||
| $3.07M-99.3% | $2.44M-99.4% | $271.99M+49.2% | $271.23M+26.3% | $411.13M+286% | ||
| —— | —— | —— | $12.51M-51.7% | $54.19M+342% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Upstream Bio, Inc. generate?
- Upstream Bio, Inc. (UPB) generated -$140.0M in operating cash flow over the trailing twelve months.
- Where does Upstream Bio, Inc.'s cash flow data come from?
- Every line is extracted from Upstream Bio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
